JPRN-UMIN000026890已完成4 期
The pharmacoepidemiological study of Zonisamide for Parkinson's disease - The pharmacoepidemiological study of Zonisamide for Parkinson's disease
Ehime University Graduate School of Medicine0 个研究点目标入组 9,157 人开始时间: 2017年4月10日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 9,157
研究概览
简要总结
The zonisamide use was significantly associated with a lower risk of dementia, insomnia, and gastric ulcers than 3 of 7 other classes without levodopa (p<.05).
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Having only sub-category of G20; 3320001, 8830558, 8841415. 2. Secandary Parkinson's diseaase, which is defined as diagnosed with ICD-10 codes of G21, G22, and G23.
研究者
相似试验
已完成
2 期
A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine HeadacheMigraine HeadacheNCT00055484Elan Pharmaceuticals204
已完成
不适用
A Study to Evaluate the Safety and Efficacy of Zonisamide an Antiepileptic Drug as Monotherapy or Adjunctive Therapy in Treatment of Adult Patients With Partial, Generalized or Combined Seizures.Partial, Generalized and Combined SeizuresNCT01283256Eisai Inc.655
已完成
2 期
ZEAL studyParkinson's diseaseParkinson's disease,SomnipathyD010300JPRN-jRCTs051200160Hiroshi Kataoka70
终止
3 期
Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised EpilepsyEpilepsyNCT00693017Eisai Limited10
已完成
2 期
A Safety/Efficacy Trial of Zonisamide for Essential TremorEssential TremorNCT00223743VA Greater Los Angeles Healthcare System25